| Literature DB >> 31857185 |
Umberto M Musazzi1, Garba M Khalid2, Francesca Selmin3, Paola Minghetti4, Francesco Cilurzo5.
Abstract
Interest in orodispersible films (ODF) is growing day-by-day, since this dosage form overcomes some therapeutic obstacles, such as impaired swallowing, and offers several benefits, such as the possibility to adapt the dosing requirements for a subset of patients. As a consequence, technologies to produce ODF have risen attention for possible applications in the development of patient-centric formulations. This review critically discusses current trends in the technology platforms proposed to manufacture ODF, including the innovation and opportunities to produce very small batches in a pharmacy setting. Although the main Pharmacopoeias recommend testing customized dosage forms for quality assurance, pharmaceutical assays are a matter of debate due to the complexity and high cost of conventional methods. Alternatively, non-disruptive online analytic methods can be proposed to assay ODF properties, above all to assure the uniformity of drug content.Entities:
Keywords: Drug printing; Flexographic printing; Individualized medicine; Orodispersible films; Solvent casting
Mesh:
Substances:
Year: 2019 PMID: 31857185 DOI: 10.1016/j.ijpharm.2019.118963
Source DB: PubMed Journal: Int J Pharm ISSN: 0378-5173 Impact factor: 5.875